Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis
Open Access
- 16 October 2024
- journal article
- research article
- Published by American Society for Microbiology in mBio
- Vol. 15 (10) , e0083324
Abstract
Secretory (S) IgA antibodies against severe acute respiratory syndrome (SARS)-CoV-2 are induced in saliva and upper respiratory tract (URT) secretions by natural infection and may be critical in determining the outcome of initial infection. Secretory IgA1 (SIgA1) is the predominant isotype of antibodies in these secretions. Neutralization of SARS-CoV-2 is most effectively accomplished by polymeric antibodies such as SIgA. We hypothesize that cleavage of SIgA1 antibodies against SARS-CoV-2 by unique bacterial IgA1 proteases to univalent Fabα antibody fragments with diminished virus neutralizing activity would facilitate the descent of the virus into the lungs to cause serious disease and also enhance its airborne transmission to others. Recent studies of the nasopharyngeal microbiota of patients with SARS-CoV-2 infection have revealed significant increases in the proportions of IgA1 protease-producing bacteria in comparison with healthy subjects. Similar considerations might apply also to other respiratory viral infections including influenza, possibly explaining the original attribution of influenza to Haemophilus influenzae , which produces IgA1 protease.Keywords
This publication has 39 references indexed in Scilit:
- SARS-CoV-2 infection induces robust mucosal antibody responses in the upper respiratory tractiScience, 2024
- SARS-CoV-2 biology and host interactionsNature Reviews Microbiology, 2024
- ‘Bold’ study that gave people COVID reveals ‘supershedder’ phenomenonNature, 2023
- Humoral response to anti-SARS-CoV-2 vaccine in breastfeeding mothers and mother-to-infant antibody transfer through breast milknpj Vaccines, 2022
- Mucosal immune responses to infection and vaccination in the respiratory tractImmunity, 2022
- SARS-CoV-2 mucosal antibody development and persistence and their relation to viral load and COVID-19 symptomsNature Communications, 2021
- Microbial Evasion of IgA Functions2015
- Structure and function relationships in IgAMucosal Immunology, 2011
- Antibody-enhanced pneumococcal adherence requires IgA1 proteaseProceedings of the National Academy of Sciences, 2003
- Anti‐inflammatory activity of human IgA antibodies and their Fabα fragments: inhibition of IgG‐mediated complement activationEuropean Journal of Immunology, 1989